A New Era in Precision Medicine: SimBioSys Announces Strategic Collaboration with Magic Leap to Advance TumorSight Platform with AR Integration
April 16 2024 - 8:02AM
Business Wire
- SimBioSys and Magic Leap join forces to integrate AI-powered
TumorSight Viz with AR technology, revolutionizing surgical
precision and patient outcomes in cancer care.
- The first demonstration of the potential of this collaboration
was recently on display at the American Society of Breast Surgeons
(ASBrS) 2024 conference in Orlando.
SimBioSys, a pioneering TechBio company unlocking the power of
spatial biophysics with artificial intelligence (AI) and
computational modeling to redefine precision medicine for cancer,
today announced a strategic collaboration with Magic Leap to
explore fusing cutting-edge technologies with the potential of
revolutionizing cancer surgery. This collaboration marks a
significant milestone in the advancement of surgical oncology,
combining SimBioSys' expertise in medical imaging AI evaluation
with Magic Leap's state-of-the-art augmented reality (AR)
technology. Together, this collaboration endeavors to empower
surgeons with innovative tools that optimize surgical precision,
minimize invasiveness, and ultimately improve patient quality of
life.
SimBioSys’ newly FDA-cleared product, TumorSight Viz, provides
surgical oncologists with unparalleled 3D spatial visualizations
and key insights of a patient's breast cancer on a web-browser,
giving clinicians a more comprehensive understanding of the
patient’s cancer and supporting more effective patient
consultations. Through this collaboration, the companies will
explore the integration of TumorSight Viz into Magic Leap 2's AR
product, revolutionizing how surgeons can interact with and
understand a patient-specific case. By enabling viewing on
immersive AR, surgeons can gain unprecedented insight into tumor
localization and surrounding anatomy, supporting more informed
treatment decision-making and enhanced patient outcomes.
"Like AI, the AR field has made incredible strides in recent
years, with Magic Leap being a recognized market leader and
trailblazer in the space,” said Barry Rosen, MD, CMO of SimBioSys
and breast surgical oncologist. “Unfortunately, other VR/AR
approaches have failed in modalities such as breast cancer where
the imaging does not reflect the patient’s position at surgery.
SimBioSys has solutions coming to market soon that can adjust for
this with our computation modeling capabilities and can help power
AR in breast cancer to have real clinical utility.”
Magic Leap 2 is an enterprise-ready AR device designed to
seamlessly bridge the gap between physical and digital worlds.
Boasting breakthrough features like Dynamic Dimming™ technology,
double the field of view, and unmatched image quality, Magic Leap 2
sets new standards for AR technology in the enterprise sector.
The first demonstrations of the dual technologies were recently
shown at the 2024 American Society of Breast Surgeons (ASBrS)
conference. The integrated SimBioSys and Magic Leap 2 workflow is
currently for educational purposes only and not FDA cleared (or
otherwise cleared) for diagnostic use or other uses.
About SimBioSys, Inc.
SimBioSys is a pioneering TechBio company harnessing the power
of spatial biophysics with artificial intelligence and
computational modeling to redefine precision medicine,
revolutionize patient care and defeat cancer. By seeing cancer more
completely, SimBioSys aims to empower clinicians, patients, and
researchers with a more informed understanding of a patient’s tumor
to optimally assess all available options and deliver on the
promise of truly individualized patient care. To learn more, visit
us at https://www.simbiosys.com/.
About Magic Leap
Magic Leap, Inc.'s technology is designed to amplify human
potential by delivering the most immersive Augmented Reality (AR)
platform, so people can intuitively see, hear, and touch digital
content in the physical world. Through the use of our advanced,
enterprise-grade AR technologies, products, platforms, and
services, we deliver innovative businesses a powerful tool for
transformation. Founded in 2010, Magic Leap, Inc. is proudly
headquartered in South Florida, with eight additional offices
across the globe.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240416255882/en/
Sarah Ellinwood, PhD The Market Element
sarah.ellinwood@themarketelement.com